||EPS - Basic
||Market Cap (m)
Biome Technologies Share Discussion Threads
Showing 7776 to 7797 of 7800 messages
|They were £1.35 when I dumped mine back in Jan 2016 so although they seem to be on the up it's not much and in my experience it won't be long before the downward creep starts again.|
|Interesting stock, I am closely monitoring this one.|
|Looks like a false market to me.
There hasn't been any buying in volume since the 95p bid price just over a week ago.- in fact not a great deal more buys than sells but the MM's have lifted it to try and generate interest.
I'd imagine the MM's have a lot of stock they'd like to offload before letting it fall back down again.|
|Won't take much buying to send this up|
|Can't argue that revenue is up but as always the question is can it be sustained??|
|don't think i will get anymore cheap shares for a while
shame as holding is small but have done well so far
is the increase in turnover sustainable and the increase in margins, that remains to be seen but at least the share price has gone in the right direction|
|Looks better but has done that oh so many times before.|
|Oi Oi whats this then.|
|You can put them in with the normal paper waste for recycling however the consumer once again will be checking which cup can and can't be recycled with paper. The presenters didn't seem to impressed either !!|
|Did I misunderstand or did he say the cups are fully recyclable unlike the current ones?|
Share price 57p
Market Cap £75m
1) ‘Lupuzor’; for Lupus currently in pivotal Phase 3 trials.
2) All patients now recruited.
3) Headline results expected Q1 2018.
4) Incremental announcements expected throughout 2017.
5) On FDA’s “fast track” “special protocol” route after strong safety and efficacy in Phase 2, so if IMM adheres to same protocol as Phase 2b and delivers positive results, FDA will not request further trial with different endpoints or outcomes.
6) Potential “multi-billion dollar sales”.
7) Currently 100% owned by IMM.
8) Very little competition, with only one other Lupus drug approved in last 50 years - GSK’s Benlysta reached sales over $400m in 2015, with annual sales predicted at $1bn by 2020.
9) IMM’s Lupuzor already demonstrated in Phase IIb that it is safer and more effective than Benlysta, and is expected to have lower pricing.
10) Fully cashed up from £4.1m fund raise in March 2017, enabling it to complete pivotal Phase 3 trials and progress other pipeline projects.
Northland Capital has a 171p current valuation on IMM.
With the blockbuster sales potential, little competition, good Phase 2 and FDA fast track status, I personally think it could be £7 to £10 if the Phase 3 results are good in Q1 2018.
|I have not lost. So not all.|
|We have all lost so much in this share over the years while PM gets his big salary but any break through here will not only help the environment but a measly 1k shares could be life changing.|
|We know the answer to that.|
|AGM on the 24th, may be these questions can be asked if temps of 50/60 degrees needed ?|
|Bioplastics has always had the potential to be huge but the main stumbling block has been price and performance. Other companies manage to get funding and products to market while biome always struggled.|
|This is standard PM stuff
Never yet been able to bring one launch to fruition. Plenty of trials etc but no contracts secured on any of the products they have touted [with the exception of the lid of the coffee pod but that is all veiled in secrecy and brings in very little revenue].
I'd agree with JMF - a prelude to a fund raiser.
Maybe Viv and Rushton have asked PM what he is doing about promoting the company so he had to go and stand in front of a camera for his regular 3 yearly ramp of a product that never leads to business.
Who remembers the tie in with McDonalds for the Olympics? or the Car parts? or the disposable gloves in petrol station forecourts? all touted before vanishing off the face of the Earth.|
|Key statement? Never before have such bioplastic materials for disposable cups and lids been made that are fully compostable and recyclable, while still performing like petroleum-based plastic under heat and stress....Compostable and recyclable...|
|In 2005 they once reached an adjusted price that is equivalent to over £700 a share :-). Now that would be nice indeed.....
Just shows you what destruction in 'value' has happened here.....:-(
|What is the current share price in old money? 0.003p?|
|But many scientists are sceptical about bioplastics.
The specific compost conditions required for them to break down include being subjected to temperatures of 50-60 degrees Celsius, as well as contact with soil and water. So they wouldn't break down in landfill or sea water.|
|We'll see. I hope you're right but experience tells me otherwise.|